Amyotrophic lateral sclerosis (ALS) is one of the most rapidly progressive
neurodegenerative diseases of unknown cause. Riluzole is the only drug that slows disease …

Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease - Ng, L - 2017 |
Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Introduction The purpose of this study was to determine the impact of an in‐home expiratory
muscle strength training (EMST) program on pulmonary, swallow, and cough function in …

Neurodegenerative diseases have reached alarming numbers in the past decade.
Unfortunately, clinical trials testing potential therapeutics have proven futile. In the absence …

Background Despite the high incidence of muscle weakness in individuals with amyotrophic
lateral sclerosis (ALS) or motor neuron disease (MND), the effects of exercise in this …

In this review, we summarize the most important recent developments in the treatment of
amyotrophic lateral sclerosis (ALS). In terms of disease-modifying treatment options, several …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that results in a
constellation of problematic symptoms and a high patient and caregiver burden …

The care and management of patients with ALS should always be patient focused, with
attention to holistic and emotional aspects of well-being. It is the patient who ultimately …

Stress mechanisms have long been associated with neuronal loss and neurodegenerative
diseases. The origin of cell stress and neuronal loss likely stems from multiple pathways …

Skeletal muscle is the most abundant tissue in healthy individuals and it has important roles
in health beyond voluntary movement. The overall mass and energy requirements of …